Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Improving the health of vulnerable communities and changing lives is at the heart of what we do and who we are.
A combination of research methods are being used observational cohorts, randomised controlled trials, implementation studies, basic science and modelling.
Our work is focusing on, but not confined to, people who inject drugs (PWID), HIV-positive (+ve) gay and bisexual men (GBM), and prisoners.
PWID and incarcerated populations are the key drivers of HCV transmission in Australia and many other countries.
In many low- and middle-income countries the epidemic is driven by unsafe medical procedures in the official and non-official health system.
More recently, in low- and middle-income countries, HIV+ve GBM have been at increased risk of HCV coinfection.
Five years
The work of this Program Grant has informed national and global strategies on hepatitis C elimination.
Professor Alex Thompson – St Vincent’s Hospital, Melbourne
NHMRC Program Grant
For any general enquiries relating to this project, please contact:
Deputy Director, Programs; Adjunct Professor, Monash University, DEPM.
To create and translate knowledge into better health, so no-one is left behind.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2023 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present.
We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.
